Clinician-Administered PTSD Scale

Foa, E.B., Tolin, D.F. (2000). Comparison of the PTSD Symptom Scale — Interview Version and the Clinician-Administered PTSD Scale. Journal of Traumatic Stress, 13, 181-191. 

In a 12-week trial involving nearly 200 adult outpatients with PTSD, preliminary data showed a significantly larger decrease in the Clinician-Administered PTSD Scale (CAPS) total score for sertraline (43%) than for placebo (31%). Sertraline also was shown to have positive effects on quality of life ( 274). In addition, sertraline has been shown to be effective in the treatment of PTSD with co-morbid alcoholism (275). 

In the second study, Ruscio, Ruscio, and Keane (2002) examined the taxonicity of PTSD in a large sample of male combat veterans (N = 1,230), who were seen at the Behavioral Sciences Division of the Veterans Affairs Boston Healthcare System s National Center for posttraumatic stress disorder between 1985 and 2000. All the participants completed the Mississippi scale (Keane, Caddell,. Taylor, 1988), a 35-item measure of combat-related posttraumatic stress disorder symptoms rated on a five-point scale a subset of this sample (n = 841) was assessed with the Clinician Administered Posttraumatic Stress Disorder Scale (CAPS), an interview measure of posttraumatic stress disorder symptoms that a clinician rates on a five-point scale. According to the CAPS, 68% of the sample qualified for a posttraumatic stress disorder diagnosis. 

---